GlaxoSmithKline Pharmaceuticals Limited: 손익 계산서 (TTM)

GlaxoSmithKline Pharmaceuticals Limited
IN ˙ BSE ˙ INE159A01016
₹2,166.30 ↓ -0.20 (-0.01%)
2026-06-05
주가
손익 계산서 (TTM)

GlaxoSmithKline Pharmaceuticals Limited 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
수익 33,403 34,708 34,861 32,780 33,048 32,875 32,739 32,517 32,683 33,084 33,114 34,537 35,067 35,605 37,046 37,492 37,397 37,089 38,007 38,217
변화 (%) 3.91 0.44 -5.97 0.82 -0.52 -0.41 -0.68 0.51 1.23 0.09 4.30 1.53 1.53 4.05 1.20 -0.25 -0.82 2.48 0.55
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 13,870 14,226 14,048 13,782 13,690 13,455 13,135 13,041 13,133 13,027 13,314 13,552 13,544 13,844 14,267 14,139 14,063 13,773 13,820 13,511
변화 (%) 2.57 -1.25 -1.89 -0.67 -1.72 -2.38 -0.71 0.71 -0.81 2.21 1.78 -0.06 2.22 3.06 -0.90 -0.53 -2.06 0.34 -2.24
수익의 % 41.52 40.99 40.30 42.04 41.43 40.93 40.12 40.11 40.18 39.37 40.21 39.24 38.62 38.88 38.51 37.71 37.60 37.14 36.36 35.35
총 영업 이익 19,533 20,482 20,813 18,998 19,357 19,420 19,604 19,476 19,549 20,057 19,799 20,985 21,523 21,761 22,779 23,354 23,334 23,316 24,187 24,706
변화 (%) 4.86 1.62 -8.72 1.89 0.32 0.95 -0.65 0.38 2.60 -1.29 5.99 2.57 1.10 4.68 2.52 -0.08 -0.08 3.74 2.14
수익의 % 58.48 59.01 59.70 57.96 58.57 59.07 59.88 59.89 59.82 60.63 59.79 60.76 61.38 61.12 61.49 62.29 62.40 62.86 63.64 64.65
판매관리비 7,629 7,689 7,521 7,397 7,238 7,057 7,163 7,062 7,200 7,233 7,116 7,358 7,220 7,275 7,109 7,018 7,031 6,905 7,176 6,072
변화 (%) 0.79 -2.19 -1.65 -2.15 -2.50 1.50 -1.41 1.95 0.45 -1.61 3.39 -1.86 0.76 -2.28 -1.28 0.18 -1.80 3.93 -15.38
수익의 % 22.84 22.15 21.57 22.57 21.90 21.47 21.88 21.72 22.03 21.86 21.49 21.30 20.59 20.43 19.19 18.72 18.80 18.62 18.88 15.89
연구개발
변화 (%)
수익의 %
운영 비용 26,825 27,370 27,167 25,792 25,880 25,689 25,229 25,033 25,254 25,347 25,490 26,147 25,811 26,014 26,734 26,349 26,038 25,596 25,735 25,789
변화 (%) 2.03 -0.74 -5.06 0.34 -0.74 -1.79 -0.78 0.88 0.37 0.56 2.58 -1.29 0.79 2.77 -1.44 -1.18 -1.70 0.54 0.21
수익의 % 80.31 78.86 77.93 78.68 78.31 78.14 77.06 76.98 77.27 76.62 76.98 75.71 73.60 73.06 72.16 70.28 69.63 69.01 67.71 67.48
영업 이익 6,578 7,338 7,694 6,988 7,168 7,186 7,510 7,484 7,428 7,737 7,623 8,390 9,256 9,591 10,313 11,144 11,359 11,494 12,272 12,428
변화 (%) 11.56 4.85 -9.17 2.56 0.26 4.50 -0.34 -0.75 4.15 -1.47 10.06 10.32 3.62 7.52 8.06 1.93 1.18 6.78 1.26
수익의 % 19.69 21.14 22.07 21.32 21.69 21.86 22.94 23.02 22.73 23.38 23.02 24.29 26.40 26.94 27.84 29.72 30.37 30.99 32.29 32.52
이자 비용 -32 -27 -24 -20 -19 -19 -14 -18 -14 -15 -17 -18 -19 -17 -15 -13 -14 -16 -27 -27
변화 (%) -16.35 -13.28 -15.11 -5.51 2.12 -25.44 26.19 -22.07 2.83 15.84 6.93 5.00 -8.47 -13.30 -12.34 3.81 17.60 68.59 0.97
수익의 % -0.10 -0.08 -0.07 -0.06 -0.06 -0.06 -0.04 -0.06 -0.04 -0.04 -0.05 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.07 -0.07
당기순이익 3,684 4,962 4,900 16,947 16,929 16,821 16,963 6,107 6,237 6,477 5,289 5,900 6,400 6,750 8,592 9,276 9,503 9,553 10,210 10,360
변화 (%) 34.68 -1.24 245.86 -0.11 -0.64 0.84 -64.00 2.12 3.86 -18.35 11.54 8.49 5.47 27.28 7.96 2.45 0.53 6.88 1.47
수익의 % 11.03 14.30 14.06 51.70 51.23 51.17 51.81 18.78 19.08 19.58 15.97 17.08 18.25 18.96 23.19 24.74 25.41 25.76 26.86 27.11

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
IN:GLAXO ₹2,166.50
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista